Cargando…

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer

BACKGROUND: Esophageal cancer represents a global challenge. Despite significant evolution of treatment protocols in the past decade, recurrence rates are still high and survival rates are poor. Current treatment paradigm for localized gastroesophageal junction (GEJ) carcinoma remains to be further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zlotnik, Oran, Goshen‐Lago, Tal, Haddad, Riad, Brenner, Baruch, Kundel, Yulia, Ben‐Aharon, Irit, Kashtan, Hanoch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955071/ https://www.ncbi.nlm.nih.gov/pubmed/34350714 http://dx.doi.org/10.1002/cnr2.1489

Ejemplares similares

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Michal, Sternschuss, et al.
Publicado: (2021)

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
por: Moore, Assaf, et al.
Publicado: (2020)

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer
por: Kundel, Yulia, et al.
Publicado: (2023)

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy
por: Wasserberg, Nir, et al.
Publicado: (2014)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
por: Kundel, Yulia, et al.
Publicado: (2020)

Young patients with cancer and a digital social network: the voice beyond the clinic
por: Ben-Aharon, Irit, et al.
Publicado: (2020)

Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity
por: Goldvaser, Hadar, et al.
Publicado: (2017)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)

Laparoscopic hand-assisted liver resection for tumours in the left lateral section
por: Sadot, Eran, et al.
Publicado: (2020)

Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity
por: Bar-Joseph, Hadas, et al.
Publicado: (2020)

The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study
por: Goshen-Lago, Tal, et al.
Publicado: (2020)

Psychosocial perspectives among cancer patients during the coronavirus disease 2019 (COVID‐19) crisis: An observational longitudinal study
por: Turgeman, Ilit, et al.
Publicado: (2021)

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
por: Goshen-Lago, Tal, et al.
Publicado: (2021)

Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
por: Ahmad, M. Usman, et al.
Publicado: (2022)

Evolving treatment paradigms in esophageal cancer
por: Turgeman, Ilit, et al.
Publicado: (2021)

1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
por: Zer, A., et al.
Publicado: (2022)

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
por: Faron, Matthieu, et al.
Publicado: (2023)

Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
por: Dickman, Ram, et al.
Publicado: (2013)

Torsion of a huge accessory spleen in a 20-year-old patient()
por: Bard, Vyacheslav, et al.
Publicado: (2013)

Paraesophageal hernia: to fundoplicate or not?
por: Solomon, Daniel, et al.
Publicado: (2021)

Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
por: Kamarajah, S. K., et al.
Publicado: (2020)

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials
por: Zhu, Jie, et al.
Publicado: (2022)

Burnout and resilience at work among health professionals serving in tertiary hospitals, in Ethiopia
por: Gelaw, Yared Mulu, et al.
Publicado: (2023)

1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients
por: Ben-Aharon, I., et al.
Publicado: (2021)

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
por: Zhao, Qun, et al.
Publicado: (2015)

Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction
por: Li, Shoumiao, et al.
Publicado: (2017)

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using (18) F-FDG PET-CT imaging. A prospective clinical study
por: Goldberg, Natalia, et al.
Publicado: (2012)

Functional Changes of the Upper Esophageal Sphincter in Gastroesophageal Reflux
por: Dantas, Roberto Oliveira
Publicado: (2021)

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Hanyang, et al.
Publicado: (2022)

Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma
por: Dzinic, Sijana H., et al.
Publicado: (2019)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
por: Brenner, Baruch, et al.
Publicado: (2016)

Correlation between esophageal pH-metry and esophagitis in gastroesophageal reflux disease in children
por: Lupu, Vasile Valeriu, et al.
Publicado: (2018)

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas
por: Ferrer-Torres, Daysha, et al.
Publicado: (2016)

Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
por: Das, Satya, et al.
Publicado: (2018)

Significance of Extra-Esophageal Symptoms in Pediatric Gastroesophageal Reflux Disease
por: Košec, Andro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d3c7kuqonlleoolb52u85p8sck